Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.00 Insider Own3.60% Shs Outstand65.28M Perf Week4.94%
Market Cap471.32M Forward P/E- EPS next Y-0.27 Insider Trans5.29% Shs Float62.26M Perf Month-6.48%
Income-62.10M PEG- EPS next Q-0.22 Inst Own68.10% Short Float20.62% Perf Quarter-29.49%
Sales155.90M P/S3.02 EPS this Y-169.90% Inst Trans2.10% Short Ratio14.39 Perf Half Y-13.53%
Book/sh4.48 P/B1.61 EPS next Y50.00% ROA-14.30% Target Price10.92 Perf Year0.70%
Cash/sh2.45 P/C2.95 EPS next 5Y- ROE-23.50% 52W Range6.36 - 10.32 Perf YTD-18.42%
Dividend- P/FCF- EPS past 5Y-18.30% ROI-17.20% 52W High-30.04% Beta2.05
Dividend %- Quick Ratio2.50 Sales past 5Y40.30% Gross Margin81.70% 52W Low13.52% ATR0.39
Employees226 Current Ratio2.60 Sales Q/Q-40.80% Oper. Margin-24.90% RSI (14)45.86 Volatility5.30% 5.52%
OptionableYes Debt/Eq0.33 EPS Q/Q-625.00% Profit Margin-43.40% Rel Volume1.00 Prev Close7.18
ShortableYes LT Debt/Eq0.33 EarningsMar 06 AMC Payout- Avg Volume891.94K Price7.22
Recom2.80 SMA20-1.08% SMA50-8.06% SMA200-14.12% Volume890,612 Change0.56%
07-Oct-13Initiated HC Wainwright Buy $15
29-May-13Initiated Burrill Institutional Research Mkt Outperform $12
13-Mar-13Reiterated RBC Capital Mkts Outperform $19 → $16
13-Mar-13Downgrade WallachBeth Buy → Sell $20 → $5.50
02-May-11Reiterated MLV Capital Buy $12.50 → $20.50
25-Mar-11Initiated RBC Capital Mkts Outperform $12
07-Dec-10Reiterated Morgan Joseph Buy $8 → $10
12-Jan-10Upgrade Morgan Joseph Hold → Buy $8
14-Oct-09Reiterated Rodman & Renshaw Mkt Outperform $10 → $8
08-Sep-09Downgrade Morgan Joseph Buy → Hold
09-Sep-08Initiated Morgan Joseph Buy $5
23-Apr-08Downgrade Oppenheimer Outperform → Perform
18-Mar-08Downgrade Brean Murray Buy → Hold
01-Nov-07Reiterated Friedman Billings Mkt Perform $5.50 → $4
31-Oct-07Reiterated Rodman & Renshaw Mkt Outperform $8 → $6
09-Oct-07Upgrade Brean Murray Hold → Buy $11
25-Jul-07Upgrade Brean Murray Sell → Hold
25-Jul-07Reiterated Lazard Capital Buy $11 → $6
25-Jul-07Downgrade Friedman Billings Outperform → Mkt Perform $12.25 → $5.50
23-Jul-07Downgrade Brean Murray Buy → Sell $11 → $4
24-Apr-14 04:50PM  Spectrum Pharma Candidate Gets Positive Data Zacks
23-Apr-14 11:58AM  Spectrum Pharma to seek cancer drug approval in 3rd qtr Reuters
07:26AM  Spectrum Pharma's cancer drug meets main goal in trial Reuters
07:13AM  Ligand's partner Spectrum says Captisol-enabled melphalan meets primary endpoint theflyonthewall.com
07:00AM  Spectrum Pharmaceuticals Pivotal Trial of Captisol-Enabled (Propylene Glycol-Free) Melphalan Meets Primary Endpoint Business Wire
21-Apr-14 07:00AM  Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer Business Wire
17-Apr-14 05:03PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events EDGAR Online
11-Apr-14 07:01AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fin EDGAR Online -5.17%
10-Apr-14 07:02AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant EDGAR Online -7.13%
08-Apr-14 04:04PM  SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Spectrum Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty Business Wire
01:13PM  Is biotech caught in a bubble, and is it popping? at MarketWatch
31-Mar-14 04:59PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and EDGAR Online
21-Mar-14 04:32PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements EDGAR Online
18-Mar-14 01:04PM  SPECTRUM PHARMACEUTICALS INC Financials EDGAR Online Financials
12-Mar-14 06:11AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online
07-Mar-14 10:02AM  Analysis Of The Near-Term Value Drivers Of Spectrum Pharmaceuticals at Seeking Alpha
10:02AM  Analysis Of The Near-Term Value Drivers Of Spectrum Pharmaceuticals
09:00AM  Spectrum Pharma Posts Lower Y/Y Q4 Earnings Zacks
09:00AM  Spectrum Pharma Posts Lower Y/Y Q4 Earnings
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 26th Annual ROTH Conference in Laguna Niguel on March 11th Business Wire
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 26th Annual ROTH Conference in Laguna Niguel on March 11th
06-Mar-14 09:10PM  Spectrum Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
09:10PM  Spectrum Pharmaceuticals Management Discusses Q4 2013 Results - Earnings Call Transcript
04:53PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:30PM  Spectrum Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:25PM  Spectrum Pharmaceuticals, Inc. Discusses Q4 2013 Results (Webcast) at Seeking Alpha
04:25PM  Spectrum Pharmaceuticals, Inc. Discusses Q4 2013 Results (Webcast)
04:00PM  Spectrum Pharmaceuticals Reports Fourth and Full Year 2013 Financial Results Business Wire
04:00PM  Spectrum Pharmaceuticals Reports Fourth and Full Year 2013 Financial Results
07:07AM  Q4 2013 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close CCBN
27-Feb-14 04:05PM  Spectrum Pharmaceuticals Announces Fourth Quarter 2013 Financial Results Teleconference and Webcast Business Wire
04:05PM  Spectrum Pharmaceuticals Announces Fourth Quarter 2013 Financial Results Teleconference and Webcast
26-Feb-14 09:26AM  Investors are betting against Spectrum Pharmaceuticals (SPPI), Should You? Zacks
09:26AM  Investors are betting against Spectrum Pharmaceuticals (SPPI), Should You?
24-Feb-14 10:39AM  The 10 Most Heavily Shorted Bio-Pharma Stocks at TheStreet
10:39AM  The 10 Most Heavily Shorted Bio-Pharma Stocks
23-Feb-14 04:55PM  3 Under-the-Radar Biotech Stocks You Need to Watch in 2014 at Motley Fool
04:55PM  3 Under-the-Radar Biotech Stocks You Need to Watch in 2014
10-Feb-14 08:34AM  Is Spectrum Pharmaceuticals, Inc. Blazing the Comeback Trail? at Motley Fool
08:34AM  Is Spectrum Pharmaceuticals, Inc. Blazing the Comeback Trail?
07-Feb-14 04:00PM  FDA to Review Spectrum Pharma' Beleodaq Zacks
04:00PM  FDA to Review Spectrum Pharma' Beleodaq
06-Feb-14 02:18PM  Spectrum rises as FDA starts lymphoma drug review AP
02:18PM  Spectrum rises as FDA starts lymphoma drug review
07:01AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Obl EDGAR Online
07:01AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Triggering Events That Accelerate or Increase a Direct Financial Obl
07:00AM  Spectrum Pharmaceuticals Announces FDAs Acceptance of NDA Filing for Beleodaq (belinostat) for Injection, a novel pan-HDAC inhibitor Business Wire
07:00AM  Spectrum Pharmaceuticals Announces FDAs Acceptance of NDA Filing for Beleodaq (belinostat) for Injection, a novel pan-HDAC inhibitor
24-Jan-14 07:54AM  Is A Short Squeeze Ahead for Spectrum Pharma (SPPI)? Zacks -6.64%
07:54AM  Is A Short Squeeze Ahead for Spectrum Pharma (SPPI)?
17-Jan-14 06:54AM  Can the Rally in Spectrum Pharmaceuticals (SPPI) Shares Continue? Zacks
06:54AM  Can the Rally in Spectrum Pharmaceuticals (SPPI) Shares Continue?
13-Jan-14 04:06PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:06PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
09-Jan-14 07:00AM  Spectrum Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference in San Francisco on January 16th Business Wire
07:00AM  Spectrum Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference in San Francisco on January 16th
07-Jan-14 04:37PM  SPPI Crosses Below Key Moving Average Level at TheStreet
04:37PM  SPPI Crosses Below Key Moving Average Level
26-Dec-13 02:26PM  Spectrum Pharmaceuticals Won't Always Disappoint, RBC Says at Barrons.com
02:26PM  Spectrum Pharmaceuticals Won't Always Disappoint, RBC Says
23-Dec-13 05:17PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Materia EDGAR Online
05:17PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Materia
19-Dec-13 03:49PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online
03:49PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Financial Statements and Exhibits
18-Dec-13 07:00AM  Spectrum Pharmaceuticals Announces Pricing of $100 Million Convertible Notes Offering Business Wire
07:00AM  Spectrum Pharmaceuticals Announces Pricing of $100 Million Convertible Notes Offering
17-Dec-13 08:32PM  Why Thompson Creek Metals, Spectrum Pharmaceuticals, and FactSet Research Systems Tumbled Today at Motley Fool -8.83%
08:32PM  Why Thompson Creek Metals, Spectrum Pharmaceuticals, and FactSet Research Systems Tumbled Today
06:02PM  Nasdaq stocks posting largest percentage decreases AP
01:29PM  Nasdaq stocks posting largest percentage decreases AP
11:42AM  SPPI Makes Notable Cross Below Critical Moving Average at Forbes
11:42AM  SPPI Makes Notable Cross Below Critical Moving Average
16-Dec-13 04:01PM  Spectrum Pharmaceuticals Announces Offering of $100 Million of Convertible Notes Business Wire
04:01PM  Spectrum Pharmaceuticals Announces Offering of $100 Million of Convertible Notes
12-Dec-13 03:30PM  Positive Results on SPPI's Oncology Products Zacks
01:04PM  SPECTRUM PHARMACEUTICALS INC Financials EDGAR Online Financials
11-Dec-13 04:00PM  SPPI Seeks U.S. Approval for Belinostat Zacks
07:08AM  Spectrum announces 'encouraging' data from MARQIBO, FOLOTYN studies at theflyonthewall.com
07:00AM  Spectrum Pharmaceuticals Highlights Encouraging FOLOTYN® and MARQIBO® Clinical Data Presented at the 55th Annual Meeting of the American Society of Hematology (ASH) Business Wire
10-Dec-13 07:00AM  Spectrum Pharmaceuticals Announces Submission of New Drug Application for Belinostat, a novel pan-HDAC inhibitor Business Wire
06-Dec-13 04:16PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
07:00AM  Spectrum Pharmaceuticals Highlights 13 Abstracts at the 55th Annual Meeting of the American Society of Hematology (ASH), New Orleans, Louisiana, December 7-10, 2013 Business Wire
Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company's commercialized drug products include FUSILEV for the treatment of patients with metastatic colorectal cancer, rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma; ZEVALIN injection for intravenous use as a prescription medication; and MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation of the anticancer drug vincristine for the treatment of adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. It also develops BELEODAQ for the treatment of various hematological and solid tumors; Captisol-enabled MELPHALAN, an intravenous formulation of MELPHALAN for clinicians and patients in the multiple myeloma transplant setting; APAZIQUONE to treat non-muscle invasive bladder cancer; and SPI-2012 for the treatment of chemotherapy-induced neutropenia. The company sells its drugs through a direct sales force in the United States; and through distributors in Europe and Japan. It has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan; collaboration agreement with Nippon Kayaku Co., Ltd.; licensing and collaboration agreement with TopoTarget A/S; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHROTRIYA RAJESH C MDChairman, CEO & PresidentSep 04Option Exercise3.41403,9481,378,5821,861,228Sep 05 08:53 PM